Sept 23 (Reuters) – Shanghai Fosun Pharmaceutical Group Co Ltd: * SAYS UNIT SIGNED LICENSING DEAL WITH AMBERSTONE FOR TCE PRODUCTS * SAYS UNIT TO PAY AMBERSTONE UP TO $236.16 MLN IN UPFRONT, R&D FEES,
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
Sept 23 (Reuters) - Target Corp: * TARGET CORPORATION DECLARES REGULAR QUARTERLY DIVIDEND * TARGET…
Gurugram (Haryana) [India], September 23: Lamose Infra LLP conducted the grand Bhoomi Pujan ceremony of…
By David Shepardson WASHINGTON, Sept 23 (Reuters) - America's aging air traffic control system —…
(Adds details) BERLIN, Sept 23 (Reuters) - Germany is set to order encryption technology worth…
VIDEO SHOWS: VIDEO STATEMENT BY UEFA PRESIDENT ALEKSANDER CEFERIN / ARCHIVE SHOTS OF CEFERIN AND…
By Michelle Nichols, John Irish and Courtney Rozen UNITED NATIONS, Sept 23 (Reuters) - Executives…